TOTAL BIO TOTAL BIOAVAILABILITY Trademark

Trademark Overview

On Thursday, December 20, 2018, a trademark application was filed for TOTAL BIO TOTAL BIOAVAILABILITY with the United States Patent and Trademark Office. The USPTO has given the TOTAL BIO TOTAL BIOAVAILABILITY trademark a serial number of 87429006. The federal status of this trademark filing is ABANDONED - AFTER EX PARTE APPEAL as of Tuesday, January 31, 2023. This trademark is owned by Ananda Scientific, Inc.. The TOTAL BIO TOTAL BIOAVAILABILITY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, for the regulation of body systems, namely, for diabetes, rheumatoid arthritis, atherosclerosis, inflammatory bowel disease, cardiac disorders, neuropathic pain, anxiety, mood disorders, epilepsy, sleep disorders, muscular diseases, like muscular dystrophy, Parkinson's disease, seizures type diseases, neurological disorders; therapeutics for health and well-being, namely, pharmaceuticals, sprays, agents, edibles in the nature of pills and tablets for the treatment of conditions such as weight control, appetite suppression, muscle relaxation, sleep disorders; all of the foregoing containing ingredients solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3% on a dry weight basis
total bio total bioavailability

General Information

Serial Number87429006
Word MarkTOTAL BIO TOTAL BIOAVAILABILITY
Filing DateThursday, December 20, 2018
Status603 - ABANDONED - AFTER EX PARTE APPEAL
Status DateTuesday, January 31, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceuticals, for the regulation of body systems, namely, for diabetes, rheumatoid arthritis, atherosclerosis, inflammatory bowel disease, cardiac disorders, neuropathic pain, anxiety, mood disorders, epilepsy, sleep disorders, muscular diseases, like muscular dystrophy, Parkinson's disease, seizures type diseases, neurological disorders; therapeutics for health and well-being, namely, pharmaceuticals, sprays, agents, edibles in the nature of pills and tablets for the treatment of conditions such as weight control, appetite suppression, muscle relaxation, sleep disorders; all of the foregoing containing ingredients solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3% on a dry weight basis
Pseudo MarkTOTAL BIO TOTAL BIO AVAILABILITY
Disclaimer with Predetermined Text"BIOAVAILABILITY"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 4, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAnanda Scientific, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDraper, UT 84020

Trademark Events

Event DateEvent Description
Tuesday, January 31, 2023ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Tuesday, January 31, 2023ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Tuesday, January 31, 2023ABANDONMENT - AFTER EX PARTE APPEAL
Tuesday, January 31, 2023EXPARTE APPEAL TERMINATED
Thursday, November 17, 2022EX PARTE APPEAL-REFUSAL AFFIRMED
Friday, December 17, 2021NOTIFICATION OF EXAMINERS STATEMENT E-MAILED
Friday, December 17, 2021EXAMINERS STATEMENT E-MAILED
Friday, December 17, 2021EXAMINERS STATEMENT - COMPLETED
Friday, October 29, 2021ASSIGNED TO EXAMINER
Tuesday, October 26, 2021JURISDICTION RESTORED TO EXAMINING ATTORNEY
Monday, May 17, 2021NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Monday, May 17, 2021SUBSEQUENT FINAL EMAILED
Monday, May 17, 2021SUBSEQUENT FINAL REFUSAL WRITTEN
Thursday, April 29, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 28, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 28, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 19, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 19, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 19, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 28, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 28, 2020NON-FINAL ACTION E-MAILED
Wednesday, October 28, 2020NON-FINAL ACTION WRITTEN
Thursday, October 15, 2020TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, July 22, 2020JURISDICTION RESTORED TO EXAMINING ATTORNEY
Monday, February 10, 2020NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Monday, February 10, 2020SUBSEQUENT FINAL EMAILED
Monday, February 10, 2020SUBSEQUENT FINAL REFUSAL WRITTEN
Monday, December 23, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 23, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 23, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 28, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 28, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 21, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 21, 2019NON-FINAL ACTION E-MAILED
Friday, June 21, 2019NON-FINAL ACTION WRITTEN
Wednesday, June 12, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 12, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 5, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 5, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 5, 2018NON-FINAL ACTION E-MAILED
Wednesday, December 5, 2018NON-FINAL ACTION WRITTEN
Monday, November 19, 2018JURISDICTION RESTORED TO EXAMINING ATTORNEY
Thursday, November 15, 2018EXAMINERS REQUEST FOR REMAND TO TTAB
Monday, October 1, 2018ASSIGNED TO EXAMINER
Monday, October 1, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 1, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 24, 2018TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, September 24, 2018EX PARTE APPEAL-INSTITUTED
Monday, September 24, 2018JURISDICTION RESTORED TO EXAMINING ATTORNEY
Monday, September 24, 2018EXPARTE APPEAL RECEIVED AT TTAB
Friday, March 23, 2018NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, March 23, 2018FINAL REFUSAL E-MAILED
Friday, March 23, 2018FINAL REFUSAL WRITTEN
Wednesday, March 7, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 7, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 28, 2018ASSIGNED TO LIE
Saturday, February 17, 2018TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, February 19, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 19, 2018NON-FINAL ACTION E-MAILED
Monday, February 19, 2018NON-FINAL ACTION WRITTEN
Friday, January 26, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 25, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 25, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 25, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 25, 2017NON-FINAL ACTION E-MAILED
Tuesday, July 25, 2017NON-FINAL ACTION WRITTEN
Monday, July 24, 2017ASSIGNED TO EXAMINER
Friday, May 5, 2017NOTICE OF PSEUDO MARK E-MAILED
Thursday, May 4, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 1, 2017NEW APPLICATION ENTERED

Related Keywords

total bioavailability disorders pharmaceuticals weight disease namely sleep diseases muscular suppression appetite